Fair AMP Act

Summary

Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 11 June 2019

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 11 June 2019

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 11 June 2019 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 11 June 2019

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 11 June 2019

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 11 June 2019

  Open at official source

Sponsors

• Maggie Hassan · D · Sponsor
• Bill Cassidy · R · Sponsor
• Sen. Stabenow, Debbie [D-MI] · D · Sponsor
• John Cornyn · R · Sponsor
• Rep. Cardin, Benjamin L. [D-MD-3] · D · Sponsor
• Todd Young · R · Sponsor
• · ssfi00 · Standing

Related records

• related to ← Affordable Medications Act
• related to ← Fair AMP Act
• related to ← Continuing Appropriations Act, 2020, and Health Extenders Act of 2019